世界中の市場調査レポートを販売!当社に無いレポートもお探しします。

レポートナンバー 0000038287

前立腺肥大症治療薬の世界市場洞察(2024年)- 2029年までの分析と予測(市場参加企業別、地域別、技術別、製品タイプ別)

Prof Research

Benign Prostatic Hyperplasia Treatment Drug Global Market Insights 2024, Analysis and Forecast to 2029, by Market Participants, Regions, Technology, Product Type

発刊日 2024/05/02

言語英語

体裁PDF/96ページ

ライセンス/価格96ページ

0000038287

Single
Site
Corporate

※ご請求は、お申込日のTTSレートで円換算し、消費税を加えた金額になります。
※本レポートは、英文です。PDF(電子媒体)での納品となります。
※本レポートは取り寄せとなりますので、申し込みからお届けまで、多少時間が掛かる場合がございます。

無料サンプル

  • サンプルはお問い合わせください。

レポート概要

本レポートは、2019年から2023年までの前立腺肥大症治療薬の世界市場規模と、2019年から2023年までのCAGRについて説明し、2029年末までの市場規模と2024年から2029年までのCAGRを予測します。

地域別セグメントについては、地域の供給、需要、主要企業、価格を2019年から2029年まで示します。

  • 調査地域
    ➣ 北アメリカ
    ➣ 南アメリカ
    ➣ アジア太平洋地域(APAC)
    ➣ ヨーロッパ
    ➣ 中東およびアフリカ(MEA)

各地域の主要国には、アメリカ、中国、日本、インド、韓国、ASEAN、ドイツ、フランス、イギリス、イタリア、スペイン、CIS、ブラジルなどが含まれます。

競合他社のセグメントについては、本レポートには、前立腺肥大症治療薬市場の世界的な主要企業と小規模企業が含まれています。

  • 各競合他社の情報
    ➣ 会社概要
    ➣ ビジネス情報
    ➣ SWOT分析
    ➣ 収益、粗利益、市場シェア
  • タイプセグメント
    ➣ アルファブロッカー(アルフゾシン、ドキサゾシン、タムスロシン、テラゾシン、シロドシン)
    ➣ 5-αリダクターゼ阻害薬(デュタステリド、フィナステリド)
    ➣ PDE5阻害薬(タダラフィル)
    ➣ 抗コリン薬(オキシブチニン、トルテロジン)
    ➣ β-3 アゴニスト(ソリフェナシン、ミラベグロン)
  • 調査企業
    ➣ Sanofi
    ➣ Pfizer
    ➣ AbbVie
    ➣ Viatris
    ➣ Waylis Therapeutics
    ➣ Organon
    ➣ Eli Lilly
    ➣ Johnson & Johnson

全企業リストが必要な場合はサンプルページを請求してください

基準年:2024年

実績データ:2019年から2023年まで

予測データ:2024年から2029まで

このレポートに関する特別な要件があればお知らせください。カスタムレポートをご提供できます。

レポート詳細

目次

Table of Contents

Chapter 1 Executive Summary

Chapter 2 Abbreviation and Acronyms

Chapter 3 Preface
3.1 Research Scope
3.2 Research Sources
3.2.1 Data Sources
3.2.2 Assumptions
3.3 Research Method

Chapter Four Market Landscape
4.1 Market Overview
4.2 Classification/Types
4.3 Application/End Users

Chapter 5 Market Trend Analysis
5.1 Introduction
5.2 Drivers
5.3 Restraints
5.4 Opportunities
5.5 Threats
5.6 Covid-19 Impact

Chapter 6 Industry Chain Analysis
6.1 Upstream/Suppliers Analysis
6.2 Benign Prostatic Hyperplasia Treatment Drug Analysis
6.2.1 Technology Analysis
6.2.2 Cost Analysis
6.2.3 Market Channel Analysis
6.3 Downstream Buyers/End Users

Chapter 7 Latest Market Dynamics
7.1 Latest News
7.2 Merger and Acquisition
7.3 Planned/Future Project
7.4 Policy Dynamics

Chapter 8 Historical and Forecast Benign Prostatic Hyperplasia Treatment Drug Market in North America (2019-2029)
8.1 Benign Prostatic Hyperplasia Treatment Drug Market Size
8.2 Benign Prostatic Hyperplasia Treatment Drug Market by End Use
8.3 Competition by Players/Suppliers
8.4 Benign Prostatic Hyperplasia Treatment Drug Market Size by Type
8.5 Key Countries Analysis
8.5.1 United States
8.5.2 Canada
8.5.3 Mexico

Chapter 9 Historical and Forecast Benign Prostatic Hyperplasia Treatment Drug Market in South America (2019-2029)
9.1 Benign Prostatic Hyperplasia Treatment Drug Market Size
9.2 Benign Prostatic Hyperplasia Treatment Drug Market by End Use
9.3 Competition by Players/Suppliers
9.4 Benign Prostatic Hyperplasia Treatment Drug Market Size by Type
9.5 Key Countries Analysis
9.5.1 Brazil
9.5.2 Argentina
9.5.3 Chile
9.5.4 Peru

Chapter 10 Historical and Forecast Benign Prostatic Hyperplasia Treatment Drug Market in Asia & Pacific (2019-2029)
10.1 Benign Prostatic Hyperplasia Treatment Drug Market Size
10.2 Benign Prostatic Hyperplasia Treatment Drug Market by End Use
10.3 Competition by Players/Suppliers
10.4 Benign Prostatic Hyperplasia Treatment Drug Market Size by Type
10.5 Key Countries Analysis
10.5.1 China
10.5.2 India
10.5.3 Japan
10.5.4 South Korea
10.5.5 Southest Asia
10.5.6 Australia

Chapter 11 Historical and Forecast Benign Prostatic Hyperplasia Treatment Drug Market in Europe (2019-2029)
11.1 Benign Prostatic Hyperplasia Treatment Drug Market Size
11.2 Benign Prostatic Hyperplasia Treatment Drug Market by End Use
11.3 Competition by Players/Suppliers
11.4 Benign Prostatic Hyperplasia Treatment Drug Market Size by Type
11.5 Key Countries Analysis
11.5.1 Germany
11.5.2 France
11.5.3 United Kingdom
11.5.4 Italy
11.5.5 Spain
11.5.6 Belgium
11.5.7 Netherlands
11.5.8 Austria
11.5.9 Poland
11.5.10 Russia

Chapter 12 Historical and Forecast Benign Prostatic Hyperplasia Treatment Drug Market in MEA (2019-2029)
12.1 Benign Prostatic Hyperplasia Treatment Drug Market Size
12.2 Benign Prostatic Hyperplasia Treatment Drug Market by End Use
12.3 Competition by Players/Suppliers
12.4 Benign Prostatic Hyperplasia Treatment Drug Market Size by Type
12.5 Key Countries Analysis
12.5.1 Egypt
12.5.2 Israel
12.5.3 South Africa
12.5.4 Gulf Cooperation Council Countries
12.5.5 Turkey

Chapter 13 Summary For Global Benign Prostatic Hyperplasia Treatment Drug Market (2019-2024)
13.1 Benign Prostatic Hyperplasia Treatment Drug Market Size
13.2 Benign Prostatic Hyperplasia Treatment Drug Market by End Use
13.3 Competition by Players/Suppliers
13.4 Benign Prostatic Hyperplasia Treatment Drug Market Size by Type

Chapter 14 Global Benign Prostatic Hyperplasia Treatment Drug Market Forecast (2024-2029)
14.1 Benign Prostatic Hyperplasia Treatment Drug Market Size Forecast
14.2 Benign Prostatic Hyperplasia Treatment Drug Application Forecast
14.3 Competition by Players/Suppliers
14.4 Benign Prostatic Hyperplasia Treatment Drug Type Forecast

Chapter 15 Analysis of Global Key Vendors
15.1 Sanofi
15.1.1 Company Profile
15.1.2 Main Business and Benign Prostatic Hyperplasia Treatment Drug Information
15.1.3 SWOT Analysis of Sanofi
15.1.4 Sanofi Benign Prostatic Hyperplasia Treatment Drug Revenue, Gross Margin and Market Share (2019-2024)
15.2 Pfizer
15.2.1 Company Profile
15.2.2 Main Business and Benign Prostatic Hyperplasia Treatment Drug Information
15.2.3 SWOT Analysis of Pfizer
15.2.4 Pfizer Benign Prostatic Hyperplasia Treatment Drug Revenue, Gross Margin and Market Share (2019-2024)
15.3 AbbVie
15.3.1 Company Profile
15.3.2 Main Business and Benign Prostatic Hyperplasia Treatment Drug Information
15.3.3 SWOT Analysis of AbbVie
15.3.4 AbbVie Benign Prostatic Hyperplasia Treatment Drug Revenue, Gross Margin and Market Share (2019-2024)
15.4 Viatris
15.4.1 Company Profile
15.4.2 Main Business and Benign Prostatic Hyperplasia Treatment Drug Information
15.4.3 SWOT Analysis of Viatris
15.4.4 Viatris Benign Prostatic Hyperplasia Treatment Drug Revenue, Gross Margin and Market Share (2019-2024)
15.5 Waylis Therapeutics
15.5.1 Company Profile
15.5.2 Main Business and Benign Prostatic Hyperplasia Treatment Drug Information
15.5.3 SWOT Analysis of Waylis Therapeutics
15.5.4 Waylis Therapeutics Benign Prostatic Hyperplasia Treatment Drug Revenue, Gross Margin and Market Share (2019-2024)
15.6 Organon
15.6.1 Company Profile
15.6.2 Main Business and Benign Prostatic Hyperplasia Treatment Drug Information
15.6.3 SWOT Analysis of Organon
15.6.4 Organon Benign Prostatic Hyperplasia Treatment Drug Revenue, Gross Margin and Market Share (2019-2024)
15.7 Eli Lilly
15.7.1 Company Profile
15.7.2 Main Business and Benign Prostatic Hyperplasia Treatment Drug Information
15.7.3 SWOT Analysis of Eli Lilly
15.7.4 Eli Lilly Benign Prostatic Hyperplasia Treatment Drug Revenue, Gross Margin and Market Share (2019-2024)
15.8 Johnson & Johnson
15.8.1 Company Profile
15.8.2 Main Business and Benign Prostatic Hyperplasia Treatment Drug Information
15.8.3 SWOT Analysis of Johnson & Johnson
15.8.4 Johnson & Johnson Benign Prostatic Hyperplasia Treatment Drug Revenue, Gross Margin and Market Share (2019-2024)
Please ask for sample pages for full companies list

Tables and Figures
Table Abbreviation and Acronyms
Table Research Scope of Benign Prostatic Hyperplasia Treatment Drug Report
Table Data Sources of Benign Prostatic Hyperplasia Treatment Drug Report
Table Major Assumptions of Benign Prostatic Hyperplasia Treatment Drug Report
Figure Market Size Estimated Method
Figure Major Forecasting Factors
Figure Benign Prostatic Hyperplasia Treatment Drug Picture
Table Benign Prostatic Hyperplasia Treatment Drug Classification
Table Benign Prostatic Hyperplasia Treatment Drug Applications
Table Drivers of Benign Prostatic Hyperplasia Treatment Drug Market
Table Restraints of Benign Prostatic Hyperplasia Treatment Drug Market
Table Opportunities of Benign Prostatic Hyperplasia Treatment Drug Market
Table Threats of Benign Prostatic Hyperplasia Treatment Drug Market
Table Covid-19 Impact For Benign Prostatic Hyperplasia Treatment Drug Market
Table Raw Materials Suppliers
Table Different Production Methods of Benign Prostatic Hyperplasia Treatment Drug
Table Cost Structure Analysis of Benign Prostatic Hyperplasia Treatment Drug
Table Key End Users
Table Latest News of Benign Prostatic Hyperplasia Treatment Drug Market
Table Merger and Acquisition
Table Planned/Future Project of Benign Prostatic Hyperplasia Treatment Drug Market
Table Policy of Benign Prostatic Hyperplasia Treatment Drug Market
Table 2019-2029 North America Benign Prostatic Hyperplasia Treatment Drug Market Size
Figure 2019-2029 North America Benign Prostatic Hyperplasia Treatment Drug Market Size and CAGR
Table 2019-2029 North America Benign Prostatic Hyperplasia Treatment Drug Market Size by Application
Table 2019-2024 North America Benign Prostatic Hyperplasia Treatment Drug Key Players Revenue
Table 2019-2024 North America Benign Prostatic Hyperplasia Treatment Drug Key Players Market Share
Table 2019-2029 North America Benign Prostatic Hyperplasia Treatment Drug Market Size by Type
Table 2019-2029 United States Benign Prostatic Hyperplasia Treatment Drug Market Size
Table 2019-2029 Canada Benign Prostatic Hyperplasia Treatment Drug Market Size
Table 2019-2029 Mexico Benign Prostatic Hyperplasia Treatment Drug Market Size
Table 2019-2029 South America Benign Prostatic Hyperplasia Treatment Drug Market Size
Figure 2019-2029 South America Benign Prostatic Hyperplasia Treatment Drug Market Size and CAGR
Table 2019-2029 South America Benign Prostatic Hyperplasia Treatment Drug Market Size by Application
Table 2019-2024 South America Benign Prostatic Hyperplasia Treatment Drug Key Players Revenue
Table 2019-2024 South America Benign Prostatic Hyperplasia Treatment Drug Key Players Market Share
Table 2019-2029 South America Benign Prostatic Hyperplasia Treatment Drug Market Size by Type
Table 2019-2029 Brazil Benign Prostatic Hyperplasia Treatment Drug Market Size
Table 2019-2029 Argentina Benign Prostatic Hyperplasia Treatment Drug Market Size
Table 2019-2029 Chile Benign Prostatic Hyperplasia Treatment Drug Market Size
Table 2019-2029 Peru Benign Prostatic Hyperplasia Treatment Drug Market Size
Table 2019-2029 Asia & Pacific Benign Prostatic Hyperplasia Treatment Drug Market Size
Figure 2019-2029 Asia & Pacific Benign Prostatic Hyperplasia Treatment Drug Market Size and CAGR
Table 2019-2029 Asia & Pacific Benign Prostatic Hyperplasia Treatment Drug Market Size by Application
Table 2019-2024 Asia & Pacific Benign Prostatic Hyperplasia Treatment Drug Key Players Revenue
Table 2019-2024 Asia & Pacific Benign Prostatic Hyperplasia Treatment Drug Key Players Market Share
Table 2019-2029 Asia & Pacific Benign Prostatic Hyperplasia Treatment Drug Market Size by Type
Table 2019-2029 China Benign Prostatic Hyperplasia Treatment Drug Market Size
Table 2019-2029 India Benign Prostatic Hyperplasia Treatment Drug Market Size
Table 2019-2029 Japan Benign Prostatic Hyperplasia Treatment Drug Market Size
Table 2019-2029 South Korea Benign Prostatic Hyperplasia Treatment Drug Market Size
Table 2019-2029 Southeast Asia Benign Prostatic Hyperplasia Treatment Drug Market Size
Table 2019-2029 Australia Benign Prostatic Hyperplasia Treatment Drug Market Size
Table 2019-2029 Europe Benign Prostatic Hyperplasia Treatment Drug Market Size
Figure 2019-2029 Europe Benign Prostatic Hyperplasia Treatment Drug Market Size and CAGR
Table 2019-2029 Europe Benign Prostatic Hyperplasia Treatment Drug Market Size by Application
Table 2019-2024 Europe Benign Prostatic Hyperplasia Treatment Drug Key Players Revenue
Table 2019-2024 Europe Benign Prostatic Hyperplasia Treatment Drug Key Players Market Share
Table 2019-2029 Europe Benign Prostatic Hyperplasia Treatment Drug Market Size by Type
Table 2019-2029 Germany Benign Prostatic Hyperplasia Treatment Drug Market Size
Table 2019-2029 France Benign Prostatic Hyperplasia Treatment Drug Market Size
Table 2019-2029 United Kingdom Benign Prostatic Hyperplasia Treatment Drug Market Size
Table 2019-2029 Italy Benign Prostatic Hyperplasia Treatment Drug Market Size
Table 2019-2029 Spain Benign Prostatic Hyperplasia Treatment Drug Market Size
Table 2019-2029 Belgium Benign Prostatic Hyperplasia Treatment Drug Market Size
Table 2019-2029 Netherlands Benign Prostatic Hyperplasia Treatment Drug Market Size
Table 2019-2029 Austria Benign Prostatic Hyperplasia Treatment Drug Market Size
Table 2019-2029 Poland Benign Prostatic Hyperplasia Treatment Drug Market Size
Table 2019-2029 Russia Benign Prostatic Hyperplasia Treatment Drug Market Size
Table 2019-2029 MEA Benign Prostatic Hyperplasia Treatment Drug Market Size
Figure 2019-2029 MEA Benign Prostatic Hyperplasia Treatment Drug Market Size and CAGR
Table 2019-2029 MEA Benign Prostatic Hyperplasia Treatment Drug Market Size by Application
Table 2019-2024 MEA Benign Prostatic Hyperplasia Treatment Drug Key Players Revenue
Table 2019-2024 MEA Benign Prostatic Hyperplasia Treatment Drug Key Players Market Share
Table 2019-2029 MEA Benign Prostatic Hyperplasia Treatment Drug Market Size by Type
Table 2019-2029 Egypt Benign Prostatic Hyperplasia Treatment Drug Market Size
Table 2019-2029 Israel Benign Prostatic Hyperplasia Treatment Drug Market Size
Table 2019-2029 South Africa Benign Prostatic Hyperplasia Treatment Drug Market Size
Table 2019-2029 Gulf Cooperation Council Countries Benign Prostatic Hyperplasia Treatment Drug Market Size
Table 2019-2029 Turkey Benign Prostatic Hyperplasia Treatment Drug Market Size
Table 2019-2024 Global Benign Prostatic Hyperplasia Treatment Drug Market Size by Region
Table 2019-2024 Global Benign Prostatic Hyperplasia Treatment Drug Market Size Share by Region
Table 2019-2024 Global Benign Prostatic Hyperplasia Treatment Drug Market Size by Application
Table 2019-2024 Global Benign Prostatic Hyperplasia Treatment Drug Market Share by Application
Table 2019-2024 Global Benign Prostatic Hyperplasia Treatment Drug Key Vendors Revenue
Figure 2019-2024 Global Benign Prostatic Hyperplasia Treatment Drug Market Size and Growth Rate
Table 2019-2024 Global Benign Prostatic Hyperplasia Treatment Drug Key Vendors Market Share
Table 2019-2024 Global Benign Prostatic Hyperplasia Treatment Drug Market Size by Type
Table 2019-2024 Global Benign Prostatic Hyperplasia Treatment Drug Market Share by Type
Table 2024-2029 Global Benign Prostatic Hyperplasia Treatment Drug Market Size by Region
Table 2024-2029 Global Benign Prostatic Hyperplasia Treatment Drug Market Size Share by Region
Table 2024-2029 Global Benign Prostatic Hyperplasia Treatment Drug Market Size by Application
Table 2024-2029 Global Benign Prostatic Hyperplasia Treatment Drug Market Share by Application
Table 2024-2029 Global Benign Prostatic Hyperplasia Treatment Drug Key Vendors Revenue
Figure 2024-2029 Global Benign Prostatic Hyperplasia Treatment Drug Market Size and Growth Rate
Table 2024-2029 Global Benign Prostatic Hyperplasia Treatment Drug Key Vendors Market Share
Table 2024-2029 Global Benign Prostatic Hyperplasia Treatment Drug Market Size by Type
Table 2024-2029 Benign Prostatic Hyperplasia Treatment Drug Global Market Share by Type

この商品のレポートナンバー

0000038287

TOP